Seattle Genetics Inc. (SGEN) Reports In-Line Q2 EPS
Tweet
Share
E-mailGet Alerts SGEN Hot Sheet
Price: $228.74 --0%
Financial Fact:
Investment income, net: 660K
Today's EPS Names:
VAXX, EGRX, AFIB, More
Financial Fact:
Investment income, net: 660K
Today's EPS Names:
VAXX, EGRX, AFIB, More
Join SI Premium – FREE
Seattle Genetics Inc. (NASDAQ: SGEN) reported Q2 EPS of ($0.15), in-line with the analyst estimate of ($0.15). Revenue for the quarter came in at $48.8 million versus the consensus estimate of $50.33 million.
For earnings history and earnings-related data on Seattle Genetics Inc. (SGEN) click here.
For earnings history and earnings-related data on Seattle Genetics Inc. (SGEN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Burry doubles down on Nebius short after stock surges 34% on earnings
- Rekor Systems, Inc. (REKR) Tops Q2 EPS by 3c
- Lamar Advertising acquires AdSource Outdoor in UPREIT deal
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
